Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
HylaPharm Logo
HylaPharm Growth Score
42
CB Rank
604043
Heat Score
20
HylaPharm is a university spinout company that develops targeted cancer therapies and cancer drugs.
Founded
obfuscation
PrivateSeed Lawrence, Kansas, United States1-10 www.hylapharm.com/
Health Care
Medical
Pharmaceutical
Overview

HylaPharm
Total Funding
obfuscation
Growth Score
42
Heat Score
20

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score42
-2 pts
in past quarter
Heat Score 20
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About HylaPharm

CB Rank
604043
HylaPharm is a university spinout company that develops targeted cancer therapies and cancer drugs.
Founded
obfuscation
PrivateSeed Lawrence, Kansas, United States1-10 www.hylapharm.com/
Health Care
Medical
Pharmaceutical

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name NanoPharm LLC
Also Known As NanoPharm
Operating Status Active
Company Type For Profit
Founders  Laird Forrest
About the Company
HylaPharm is a university spinout company that develops targeted cancer therapies and cancer drugs. It offers HylaPlat, a new cancer drug that has already shown efficacy in multiple mouse models, and in several dogs with large, naturally occurring cancers.
Phone Number (785) 371-0147
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Injectable Cancer Therapies
Injectable drugs designed to reverse tumor-induced immune suppression, making tumors more responsive to immune system attack.
Intra-tumor Cisplatin Drug (HylaPlat)
A nanoparticle formulation of cisplatin designed for local injection into tumors to enhance drug retention and target cancer cells and lymph nodes.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - HylaPharm Logo
Seed Round - HylaPharm
—
obfuscation
— Seed
obfuscation
Seed Round - HylaPharm Logo
Seed Round - HylaPharm
—
obfuscation
— Seed
obfuscation
Seed Round - HylaPharm Logo
Seed Round - HylaPharm
—
obfuscation
— Seed
obfuscation
Seed Round - HylaPharm Logo
Seed Round - HylaPharm
—
obfuscation
— Seed
obfuscation
Seed Round - HylaPharm Logo
Seed Round - HylaPharm
—
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - HylaPharm Logo
Seed Round - HylaPharm
—
obfuscation
— Seed
obfuscation
Seed Round - HylaPharm Logo
Seed Round - HylaPharm
—
obfuscation
— Seed
obfuscation
Seed Round - HylaPharm Logo
Seed Round - HylaPharm
—
obfuscation
— Seed
obfuscation
Seed Round - HylaPharm Logo
Seed Round - HylaPharm
—
obfuscation
— Seed
obfuscation
Seed Round - HylaPharm Logo
Seed Round - HylaPharm
—
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Contacts 2

Employee Profiles

News
Technology
View Tech Report

IT Spend

$117.4KThis year, HylaPharm is projected to spend $117.4K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Video Game Patent Logo
Video Game Patent
80
Fittest Cities Logo
Fittest Cities
78
Innovation Logo
Innovation
78

Active Website Tech Count

4HylaPharm is actively using 4 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, reCAPTCHA, and  SPF.

Total IP

2The intellectual property of HylaPharm includes 2 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is HylaPharm's headquarters? HylaPharm is located in Lawrence, Kansas, United States.When was the last funding round for HylaPharm? HylaPharm closed its last funding round on
obfuscation
from a Seed round.Who are HylaPharm's competitors? Alternatives and possible competitors to HylaPharm may include Whitehawk Therapeutics, Nanobiotix, and  ImaginAb.How much funding has HylaPharm raised to date? HylaPharm has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(882d4b2 1)
|